Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group

The National Cancer Institute (NCI)‐sponsored Chronic Lymphocytic Leukemia (CLL) Working Group was convened to develop a set of standardized eligibility, response, and toxicity criteria for clinical trials. We recognized the previous efforts in 1967 published again in 1973 as the report of the Chron...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hematology 1988-11, Vol.29 (3), p.152-163
Hauptverfasser:	Cheson, Bruce D., Bennett, John M., Rai, Kanti R., Grever, Michael R., Kay, Neil E., Schiffer, Charles A., Oken, Martin M., Keating, Michael J., Boldt, David H., Kempin, Sanford J., Foon, Kenneth A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - adverse effects Antineoplastic Agents - standards Biological and medical sciences Clinical Trials as Topic - standards CLL complete response Drug Evaluation - standards Eligibility Determination - standards Health Planning Health Planning Guidelines Hematologic and hematopoietic diseases Humans Infection - etiology Leukemia, B-Cell - diagnosis Leukemia, B-Cell - drug therapy Leukemia, Lymphocytic, Chronic, B-Cell - blood Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Leukemia, Lymphocytic, Chronic, B-Cell - pathology Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Medical sciences National Institutes of Health (U.S.) Neoplasm Staging partial response Prognosis Rai and Binet systems United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!